5BEUTLER E. G6PD: population genetics and clinical manifesta- tions[J]. BloodRev, 1996, 10(1):45-52.
6KORHONEN R, LAHTI A, HAMALAINEN M, et al. Dexame- thasone inhibits inducible nitric -oxide synthase expression and ni- tric oxide production by destabilizing mRNA in lipopolysaccharide - treated maerophages [ J ]. Mol Pharmaeol, 2002, 62 ( 3 ) : 698 - 704.
7CUTILLO S, COSTA S, VINTULEDDU M, et al. Salicylamide - Glucuronide formation in children with favism and in their parents [J]. Acta Haematol, 1976, 55(5 -2) : 296 -299.
8GAETANI G F, ROLFO M, ARENA S, et al. Active involvement of catalase during hemolytic crises of favism[ J]. Blood, 1996, 88 (3) : 1084 -1088.
9HUO Y, RANGARAJAN P, LING E A, et al. Dexamethas one inhibits the Nox - dependent ROS production via suppression of MKP - 1 - dependent MAPK pathways in activated microglia [ J ]. BMC Neurosei, 2011, 12(1): 49-67.
